Publications
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer2015 | Second Faculty of Medicine
- Paricalcitol (19-nor-) and calcitriol (1,25-dihydroxycholecalciferol) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells2011 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials2011 | Second Faculty of Medicine
- Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells2009 | Second Faculty of Medicine
- Metabolites and analogues of vitamin D2007 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Metabolites and analogues of vitamin D2007 | Second Faculty of Medicine
- Vitamin D and immune system - theory and our experience2007 | Second Faculty of Medicine
- Impaired Toll-like receptor 8-mediated IL-6 and TNF-alpha production in antigen-presenting cells from patients with X-linked agammaglobulinemia +12007 | Second Faculty of Medicine
- In vitro assessment of dendritic cells pulsed with apoptotic tumor cells as a vaccine for ovarian cancer patients2007 | Second Faculty of Medicine
- Dendritic cells in immunopathologyPublication without faculty affiliation
Loading network view...